Ngm Biopharmaceuticals
(NASDAQ) NGM
Ngm Biopharmaceuticals Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$4.42M
Net Income (TTM)
$139.83M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
NGM News
NGM: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Ngm Biopharmaceuticals
Industry
Pharmaceuticals
Sector
Health CareEmployees
138
CEO
David J. Woodhouse, PhD, MBA
Website
www.ngmbio.comHeadquarters
South San Francisco, CA 94080, US
NGM Financials
Key Financial Metrics (TTM)
Gross Margin
50%
Operating Margin
-33%
Net Income Margin
-32%
Return on Equity
-70%
Return on Capital
-98%
Return on Assets
-84%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$2.20M
Operating Income
$146.55M
EBITDA
$144.33M
Operating Cash Flow
$132.20M
Capital Expenditure
$1.25M
Free Cash Flow
$133.45M
Cash & ST Invst.
$147.18M
Total Debt
$0.00
Ngm Biopharmaceuticals Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$165.00K
-99.1%
Gross Profit
$353.00K
-102.1%
Gross Margin
-2.14%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
138
N/A
Net Income
$27.67M
+20.0%
EBITDA
$24.61M
+27.2%
Quarterly Fundamentals
Net Cash
$147.18M
-44.7%
Accounts Receivable
$58.00K
-99.2%
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$0.00
-100.0%
Return on Assets
-84.31%
N/A
Return on Invested Capital
-98.49%
N/A
Free Cash Flow
$23.15M
+24.9%
Operating Cash Flow
$22.96M
+24.5%